nmpЖурнал им. Н.В. Склифосовского «Неотложная медицинская помощь»Russian Sklifosovsky Journal "Emergency Medical Care"2223-90222541-8017“N.V. Sklifosovsky Research Institute for Emergency Medicine”10.23934/2223-9022-2017-6-2-112-113nmp-361Research ArticleОБЗОРЫ ЛИТЕРАТУРЫREVIEWS OF LITERATUREПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМPROGNOSTIC IMPORTANCE OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROMEАлиджановаХ. Г.AlidzhanovaK. G.

доктор медицинских наук, старший научный сотрудник отделения неотложной клинической кардиологии с методами неинвазивной функциональной диагностики,

Москва

Dr. Med. Sci., senior researcher at the Department of Emergency Clinical Cardiology and Non-invasive Functional Diagnostics,

Moscow

doctorhafiza@mail.ruРжевскаяО. Н.RzhevskayaO. N.

Москва

Moscow

СагировМ. А.SagirovM. A.

Москва

Moscow

ГазарянГ. А.GazaryanG. A.

Москва

Moscow

ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»РоссияN.V. Sklifosovsky Research Institute for Emergency Medicicne of the Moscow Health DepartmentRussian Federation20172506201762132139Copyright © Алиджанова Х.Г., Ржевская О.Н., Сагиров М.А., Газарян Г.А., 20172017Алиджанова Х.Г., Ржевская О.Н., Сагиров М.А., Газарян Г.А.Alidzhanova K.G., Rzhevskaya O.N., Sagirov M.A., Gazaryan G.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jnmp.ru/jour/article/view/361

Изучение острого коронарного синдрома (ОКС) у больных хронической болезнью почек (ХБП) является одним из направлений современной кардиологии. Распространенность, течение, прогноз и тактика лечения инфаркта миокарда при ХБП недостаточно изучены. Анализ литературных источников позволяет констатировать: ХБП при ОКС удваивает риск смерти (РС) и неблагоприятных сердечно-сосудистых событий в ближайшем и отдаленном периодах; определение стадии ХБП необходимо с целью прогнозирования госпитальной и отдаленной смертности инфарктных больных; диагностика ОКС на поздних стадиях ХБП сложна; ХБП следует считать независимым РС после проведения чрескожных коронарных вмешательств и коронарного шунтирования.

The study of acute coronary syndrome (ACS) in patients with chronic kidney disease (CKD) is one of the areas of modern cardiology. The prevalence, course, prognosis and tactics of treatment of myocardial infarction in CKD are not well understood. The analysis of literature sources allows us to state that CKD in ACS doubles the risk of immediate and long-term death and adverse cardiovascular events. It is necessary to determine the CKD stage to predict the hospital and long-term mortality of the infarct patient. It is difficult to diagnose ACS at advanced stages of CKD. CKD should be considered an independent risk of death after percutaneous coronary intervention and coronary bypass surgery.

хроническая болезнь почекскорость клубочковой фильтрацииатеросклероз коронарных артерийострый коронарный синдромреваскуляризация миокардаchronic kidney diseaseglomerular filtration ratecoronary atherosclerosisacute coronary syndromemyocardial revascularizationReferencesМоисеев B.C., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио- и нефропротекции. Российский кардиологический журнал. 2014; 8(112): 7–37.Moiseev B.C., Mukhin N.A., Smirnov A.V., et al. Cardiovascular risk and chronic kidney disease: cardio-nephroprotection strategies. Rossiyskiy kardiologicheskiy zhurnal. 2014; 8(112): 7–37. (In Russian).Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007; 29(23): 2630–2633. DOI: 10.1001/jama.297.23.2630.Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007; 29(23): 2630–2633. DOI: 10.1001/jama.297.23.2630.Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15(5): 1307–1315. PMID: 15100371.Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004; 15(5): 1307–1315. PMID: 15100371.Briasoulis A., Bakris G.L. Chronic kidney disease as a coronary artery disease risk equivalent. Curr. Cardiol. Rep.2013; 15(3): 340. DOI: 10.1007/s11886-012-0340-4.Briasoulis A., Bakris G.L. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013; 15(3): 340. DOI: 10.1007/s11886-012-0340-4.Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann. Intern. Med. 2002; 137(7): 563–570. DOI: 10.7326/0003-4819-137-7-200210010-00007.Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med. 2002; 137(7): 563–570. DOI: 10.7326/0003-4819-137-7-200210010-00007.Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am. J. Kidney Dis. 1998; 32(5): 853–906. DOI: 10.1016/S0272-6386(98)70145-3.Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am J Kidney Dis. 1998; 32(5): 853–906. DOI: 10.1016/S0272-6386(98)70145-3.Herzog C.A., Li S., Weinhandl E.D., et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005; 68(2): 818–825. DOI: 10.1111/j.1523-1755.2005.00462.x.Herzog C.A., Li S., Weinhandl E.D., et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005; 68(2): 818–825. DOI: 10.1111/j.1523-1755.2005.00462.x.Franczyk-Skóra B., Gluba A., Olszewski R., et al. Heart function disturbances in chronic kidney disease – echocardiographic indices. Arch. Med. Sci. 2014; 10(6): 1109–1116. DOI: 10.5114/aoms.2014.47822.Franczyk-Skóra B., Gluba A., Olszewski R., et al. Heart function disturbances in chronic kidney disease – echocardiographic indices. Arch Med Sci. 2014; 10(6): 1109–1116. DOI: 10.5114/aoms.2014.47822.Kilickesmez K.O., Abaci O., Okcun B., et al. Chronic kidney disease as a predictor of coronary lesion morphology. Angiology. 2010; 61(4): 344–349. DOI: 10.1177/0003319709351875.Kilickesmez K.O., Abaci O., Okcun B., et al. Chronic kidney disease as a predictor of coronary lesion morphology. Angiology. 2010; 61(4): 344–349. DOI: 10.1177/0003319709351875.Sabe M.A., Claggett B., Burdmann E.A., et al. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J. Am. Heart Assoc. 2016; 5(4): e002850. DOI: 10.1161/JAHA.115.002850.Sabe M.A., Claggett B., Burdmann E.A., et al. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J Am Heart Assoc. 2016; 5(4): e002850. DOI: 10.1161/JAHA.115.002850.Balla S., Nusair M.B., Alpert M.A. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin. Pharmacol. 2013; 13(2): 192–199. DOI: 10.1016/j.coph.2012.12.001.Balla S., Nusair M.B., Alpert M.A. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin Pharmacol. 2013; 13(2): 192–199. DOI: 10.1016/j.coph.2012.12.001Olechnowicz-Tietz S., Gluba A., Paradowska A., et al. The risk of atherosclerosis in patients with chronic kidney disease. Int. Urol. Nephrol. 2013; 45(6): 1605–1612. DOI: 10.1007/s11255-013-0407-1.Olechnowicz-Tietz S., Gluba A., Paradowska A., et al. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013; 45(6): 1605–1612. DOI: 10.1007/s11255-013-0407-1.Schlieper G., Schurgers L., Brandenburg V., et al. Vascular calcification in chronic kidney disease: an update. Nephrol. Dial. Transplant. 2016; 31(1): 31–39. DOI: 10.1093/ndt/gfv111.Schlieper G., Schurgers L., Brandenburg V., et al. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant. 2016; 31(1): 31–39. DOI: 10.1093/ndt/gfv111.Gupta J., Mitra N., Kanetsky P.A., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin. J. Am. Soc. Nephrol. 2012; 7(12): 1938–1946. DOI: 10.2215/CJN.03500412.Gupta J., Mitra N., Kanetsky P.A., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin J Am Soc Nephrol. 2012; 7(12): 1938–1946. DOI: 10.2215/CJN.03500412.Gupta J., Dominic E.A., Fink J.C., et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC Study. PLoS ONE. 2015; 10(4): e0124772. DOI: 10.1371/journal.pone.0124772.Gupta J., Dominic E.A., Fink J.C., et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC Study. PLoS ONE. 2015; 10(4): e0124772. DOI: 10.1371/journal.pone.0124772.Kato K., Yonetsu T., Jia H., et al. Non–culprit coronary plaque characteristics of chronic kidney disease. Circ. Cardiovasc. Imaging. 2013; 6(3): 448–456. DOI: 10.1161/CIRCIMAGING.112.000165.Kato K., Yonetsu T., Jia H., et al. Non-culprit coronary plaque characteristics of chronic kidney disease. Circ Cardiovasc Imaging. 2013; 6(3): 448–456. DOI: 10.1161/CIRCIMAGING.112.000165.Madhavan M.V., Tarigopula M., Mintz G.S., et al. Coronary artery calcification: pathogenesis and prognostic implications. J. Am. Coll. Cardiol. 2014; 63(17): 1703–1714. DOI: 10.1016/j.jacc.2014.01.017.Madhavan M.V., Tarigopula M., Mintz G.S., et al. Coronary artery calcification: pathogenesis and prognostic implications. J Am Coll Cardiol. 2014; 63(17): 1703–1714. DOI: 10.1016/j.jacc.2014.01.017.Goodman W.G., London G., Amann K., et al. Vascular calcification in chronic kidney disease. Am. J. Kidney Dis. 2004; 43(3): 572–579. PMID: 14981617.Goodman W.G., London G., Amann K., et al. Vascular calcification in chronic kidney disease. Am J Kidney Dis. 2004; 43(3): 572–579. PMID: 14981617.Kiu Weber C.I., Duchateau-Nguyen G., Solier C., et al. Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clin. Kidney J. 2014; 7(2): 167–173. DOI: 10.1093/ckj/sfu017.Kiu Weber C.I., Duchateau-Nguyen G., Solier C., et al. Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clin Kidney J. 2014; 7(2): 167–173. DOI: 10.1093/ckj/sfu017.Kawai H., Sarai M., Motoyama S., et al. Coronary plaque characteristics in patients with mild chronic kidney disease. Analysis by 320-row area detector computed tomography. Circ. J. 2012; 76(6): 1436–1441. PMID: 22453001.Kawai H., Sarai M., Motoyama S., et al. Coronary plaque characteristics in patients with mild chronic kidney disease. Analysis by 320-row area detector computed tomography. Circ J. 2012; 76(6): 1436–1441. PMID: 22453001.Ohtake T., Kobayashi S., Moriya H., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J. Am. Soc. Nephrol. 2005; 16(4): 1141–1148. DOI: 10.1681/ASN.2004090765.Ohtake T., Kobayashi S., Moriya H., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005; 16(4): 1141–1148. DOI: 10.1681/ASN.2004090765.Nakano T., Ninomiya T., Sumiyoshi S., et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am. J. Kidney Dis. 2010; 55(1): 21–30. DOI: 10.1053/j.ajkd.2009.06.034.Nakano T., Ninomiya T., Sumiyoshi S., et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am J Kidney Dis. 2010; 55(1): 21–30. DOI: 10.1053/j.ajkd.2009.06.034Charytan D.M., Shelbert H.R., Di Carli M.F. Coronary microvascular function in early chronic kidney disease. Circ. Cardiovasc. Imaging. 2010; 3(6): 663–671. DOI: 10.1161/CIRCIMAGING.110.957761.Charytan D.M., Shelbert H.R., Di Carli M.F. Coronary microvascular function in early chronic kidney disease. Circ Cardiovasc Imaging. 2010; 3(6): 663–671. DOI: 10.1161/CIRCIMAGING.110.957761.Matsushita K., Coresh J., Sang Y., et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015; 3(7): 514–525. DOI: 10.1016/S2213-8587(15)00040-6.Matsushita K., Coresh J., Sang Y., et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015; 3(7): 514–525. DOI: 10.1016/S2213-8587(15)00040-6.Tonelli M., Muntner P., Lloyd A., et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844): 807–814. DOI: 10.1016/S0140-6736(12)60572-8.Tonelli M., Muntner P., Lloyd A., et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844): 807–814. DOI: 10.1016/S0140-6736(12)60572-8.McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med. 2007; 67(11): 1122–1129. DOI: 10.1001/archinte.167.11.1122.McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med. 2007; 67(11): 1122–1129. DOI: 10.1001/archinte.167.11.1122.Hui X., Matsushita K., Sang Y., et al. CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race. Am. J. Kidney Dis. 2013; 62(4): 691–702. DOI: 10.1053/j.ajkd.2013.04.010.Hui X., Matsushita K., Sang Y., et al. CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race. Am J Kidney Dis. 2013; 62(4): 691–702. DOI: 10.1053/j.ajkd.2013.04.010.Masoudi F.A., Plomondon M.E., Magid D.J., et al. Renal insufficiency and mortality from acute coronary syndromes. Am. Heart J. 2004; 147(4): 623–629. DOI: 10.1016/j.ahj.2003.12.010.Masoudi F.A., Plomondon M.E., Magid D.J., et al. Renal insufficiency and mortality from acute coronary syndromes. Am Heart J. 2004; 147(4): 623–629. DOI: 10.1016/j.ahj.2003.12.010.Smith G.L., Masoudi F.A., Shlipak M.G., et al. Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction. J. Am. Soc. Nephrol. 2008; 19(1): 141–150. DOI: 10.1681/ASN.2007050554.Smith G.L., Masoudi F.A., Shlipak M.G., et al. Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction. J Am Soc Nephrol. 2008; 19(1): 141–150. DOI: 10.1681/ASN.2007050554.Rozenbaum Z., Leader A., Neuman Y., et al. Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome. Am. J. Med. 2016; 129(2): 187–194. DOI: 10.1016/j.amjmed.2015.08.017.Rozenbaum Z., Leader A., Neuman Y., et al. Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome. Am J Med. 2016; 129(2): 187–194. DOI: 10.1016/j.amjmed.2015.08.017.Ozaki T., Yamada T., Morita T., et al. The ratio of contrast media volume to the estimated glomerular filtration rate and syntax score predict 3-year poor outcome in patients with acute coronary syndrome and chronic kidney disease undergoing emergency coronary procedure. J. Am. Coll. Cardiol. 2016; 67(13 Suppl): S70.Ozaki T., Yamada T., Morita T., et al. The ratio of contrast media volume to the estimated glomerular filtration rate and syntax score predict 3-year poor outcome in patients with acute coronary syndrome and chronic kidney disease undergoing emergency coronary procedure. J Am Coll Cardiol. 2016; 67(13 Suppl): S70.Pun P.H., Al-Khatib S.M., Han J.Y., et al. Implantable cardioverterdefibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am. J. Kidney Dis. 2014; 64(1): 32–39. DOI: 10.1053/j.ajkd.2013.12.009.Pun P.H., Al-Khatib S.M., Han J.Y., et al.Implantable cardioverterdefibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am J Kidney Dis. 2014; 64(1): 32–39. DOI: 10.1053/j.ajkd.2013.12.009.Inrig J.K., Patel U.D., Briley L.P., et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol. Dial. Transplant. 2008; 23(3): 934–940. DOI: 10.1093/ndt/gfm689.Inrig J.K., Patel U.D., Briley L.P., et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol Dial Transplant. 2008; 23(3): 934–940. DOI: 10.1093/ndt/gfm689.Fox C.S., Muntner P., Chen A.Y., et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry. Circulation. 2010; 121(3): 357–365. DOI: 10.1161/CIRCULATIONAHA.109.865352.Fox C.S., Muntner P., Chen A.Y., et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry. Circulation. 2010; 121(3): 357–365. DOI: 10.1161/CIRCULATIONAHA.109.865352.Lee S.H., Kim YJ, Kim W., et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ. J. 2008; 72(9): 1410–1418. PMID: 18724014.Lee S.H., Kim YJ, Kim W., et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ J. 2008; 72(9): 1410–1418. PMID: 18724014.Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002; 106(8): 974–980. PMID: 12186803.Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002; 106(8): 974–980. PMID: 12186803.Cardarelli F., Bellasi A., Ou F.S., et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103(6): 766–771. DOI: 10.1016/j.amjcard.2008.11.033.Cardarelli F., Bellasi A., Ou F.S., et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am J Cardiol. 2009; 103(6): 766–771. DOI: 10.1016/j.amjcard.2008.11.033.Saad M., Karam B., Faddoul G., et al. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int. J. Nephrol. Renovasc. Dis. 2016; 9: 5–10. DOI: 10.2147/IJNRD.S91567.Saad M., Karam B., Faddoul G., et al. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int J Nephrol Renovasc Dis. 2016; 9: 5–10. DOI: 10.2147/IJNRD.S91567.Seifert M.E., de Las Fuentes L., Ginsberg C., et al. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am. J. Nephrol. 2014; 39(5): 392–399. DOI: 10.1159/000362251.Seifert M.E., de Las Fuentes L., Ginsberg C., et al. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am J Nephrol. 2014; 39(5): 392–399. DOI: 10.1159/000362251.Collins A.J., Foley R., Herzog C., et al. Excerpts from the United States Renal Data System 2007 annual data report. Am. J. Kidney Dis. 2008; 51(1 Suppl 1): S1–S320. DOI: 10.1053/j.ajkd.2007.11.001.Collins A.J., Foley R., Herzog C., et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008; 51(1 Suppl 1): S1–S320. DOI: 10.1053/j.ajkd.2007.11.001.Sittichanbuncha Y., Sricharoen P., Tangkulpanich P., Sawanyawisuth K. The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients. Ther. Clin. Risk. Manag. 2015; 11: 1143–1147. DOI: 10.2147/TCRM.S85671.Sittichanbuncha Y., Sricharoen P., Tangkulpanich P., Sawanyawisuth K. The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients. Ther Clin Risk Manag. 2015; 11: 1143–1147. DOI: 10.2147/TCRM.S85671.Twerenbold R., Wildi K., Jaeger C., et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015; 131(23): 2041–2050. DOI: 10.1161/CIRCULATIONAHA.114.014245.Twerenbold R., Wildi K., Jaeger C., et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015; 131(23): 2041–2050. DOI: 10.1161/CIRCULATIONAHA.114.014245.Bangalore S., Guo Y., Samadashvili Z., et al. Revascularization in Patients with Multivessel Coronary Artery Disease and Chronic Kidney Disease Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery. J. Am. Coll. Cardiol. 2015; 66(11): 1209–1220. DOI: 10.1016/j.jacc.2015.06.1334.Bangalore S., Guo Y., Samadashvili Z., et al. Revascularization in Patients with Multivessel Coronary Artery Disease and Chronic Kidney Disease Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery. J Am Coll Cardiol. 2015; 66(11): 1209–1220. DOI: 10.1016/j.jacc.2015.06.1334.Szummer K., Lundman P., Jacobson S.H., et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009; 120(10): 851–858. DOI: 10.1161/CIRCULATIONAHA.108.838169.Szummer K., Lundman P., Jacobson S.H., et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009; 120(10): 851–858. DOI: 10.1161/CIRCULATIONAHA.108.838169.Baber U., Mehran R. Coronary Artery Revascularization in Chronic Kidney Disease Time for a Randomized Trial. Circ. Cardiovasc. Interv. 2015; 8(1): e002140. DOI: 10.1161/CIRCINTERVENTIONS.114.002140.Baber U., Mehran R. Coronary Artery Revascularization in Chronic Kidney Disease Time for a Randomized Trial. Circ Cardiovasc Interv. 2015; 8(1): e002140. DOI: 10.1161/CIRCINTERVENTIONS.114.002140.James M.T., Pannu N. Early-invasive strategies for the management of coronary heart disease in chronic kidney disease: is acute kidney injury a consideration? Curr. Opin. Nephrol. Hypert. 2014; 23(3): 283–290. DOI: 10.1097/01.mnh.0000444819.03121.4b.James M.T., Pannu N. Early-invasive strategies for the management of coronary heart disease in chronic kidney disease: is acute kidney injury a consideration? Curr Opin Nephrol Hypert. 2014; 23(3): 283–290. DOI: 10.1097/01.mnh.0000444819.03121.4b.Shroff G.R., Solid C.A., Herzog C.A. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013; 127(18): 1861–1869. DOI: 10.1161/CIRCULATIONAHA.112.001264.Shroff G.R., Solid C.A., Herzog C.A. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013; 127(18): 1861–1869. DOI: 10.1161/CIRCULATIONAHA.112.001264.Ertelt K., Généreux P., Mintz G.S., et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am. J. Cardiol. 2013; 112(11): 1730–1737. DOI: 10.1016/j.amjcard.2013.07.038.Ertelt K., Généreux P., Mintz G.S., et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol. 2013; 112(11): 1730–1737. DOI: 10.1016/j.amjcard.2013.07.038.Castagna M.T., Mintz G.S., Ohlmann P., et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005; 111(9): 1148–1152. DOI: 10.1161/01.CIR.0000157160.69812.55.Castagna M.T., Mintz G.S., Ohlmann P., et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005; 111(9): 1148–1152. DOI: 10.1161/01.CIR.0000157160.69812.55.Roberts J.K., McCullough P.A. The management of acute coronary syndromes in patients with chronic kidney disease. Adv. Chronic. Kidney Dis. 2014; 21(6): 472–479. DOI: 10.1053/j.ackd.2014.08.005.Roberts J.K., McCullough P.A. The management of acute coronary syndromes in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2014; 21(6): 472–479. DOI: 10.1053/j.ackd.2014.08.005.Rhee J.W., Wiviott S.D., Scirica B.M., et al. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin. Cardiol. 2014; 37(6): 350–356. DOI: 10.1002/clc.22253.Rhee J.W., Wiviott S.D., Scirica B.M., et al. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin Cardiol. 2014; 37(6): 350–356. DOI: 10.1002/clc.22253.Palmer S.C., Di Micco L., Razavian M. et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013; 2: CD008834. DOI: 10.1002/14651858.CD008834.pub2.Palmer S.C., Di Micco L., Razavian M., et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013; 2: CD008834. DOI: 10.1002/14651858.CD008834.pub2.Nauta S.T., van Domburg R.T., Nuis R.J., et al. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int. 2013; 84(2): 353–358. DOI: 10.1038/ki.2013.71.Nauta S.T., van Domburg R.T., Nuis R.J., et al. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int. 2013; 84(2): 353–358. DOI: 10.1038/ki.2013.71.Kurtul A., Murat S.N., Yarlioglues M., et al. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. Angiology. 2015; 66(7): 644–651. DOI: 10.1177/0003319714546738.Kurtul A., Murat S.N., Yarlioglues M., et al. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. Angiology. 2015; 66(7): 644-651. DOI: 10.1177/0003319714546738.Tsai T.T., Messenger J.C., Brennan M.J., et al. Safety and efficacy of drugeluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J. Am. Coll. Cardiol. 2011; 58(18): 1859–1869. DOI: 10.1016/j.jacc.2011.06.056.Tsai T.T., Messenger J.C., Brennan M.J., et al. Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J Am Coll Cardiol. 2011; 58(18): 1859–1869. DOI: 10.1016/j.jacc.2011.06.056.Chan W., Ivanov J., Ko D., et al. Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario. Circ. Cardiovasc. Interv. 2015; 8(1): e001973. DOI: 10.1161/CIRCINTERVENTIONS.114.001973.Chan W., Ivanov J., Ko D., et al. Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario. Circ Cardiovasc Interv. 2015; 8(1): e001973. DOI: 10.1161/CIRCINTERVENTIONS.114.001973.Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2015; 10(9): 1024–1094. DOI: 10.4244/EIJY14M09_01.Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2015; 10(9): 1024–1094. DOI: 10.4244/EIJY14M09_01.Bangalore S., Vlachos H.A., Selzer F., et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc. Interv. 2011; 77(1): 22–28. DOI: 10.1002/ccd.22613.Bangalore S., Vlachos H.A., Selzer F., et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc. Interv. 2011; 77(1): 22–28. DOI: 10.1002/ccd.22613.Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA. 2005; 293(17): 2126–2130. DOI: 10.1001/jama.293.17.2126.Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA. 2005; 293(17): 2126–2130. DOI: 10.1001/jama.293.17.2126.

The authors declare that there are no conflicts of interest present.